From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS

Neuron

Volumn 24, Issue 3, 1999, Pages 515-520

  Cleveland, Don W ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; GENE MUTATION; HUMAN; MOTOR NEURON DISEASE; NERVE CELL NECROSIS; NERVE FIBER TRANSPORT; NEUROFILAMENT; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033231494     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)81108-3     Document Type: Review

References (40)

1. Al-Chalabi, A., Andersen, P.M., Nilsson, P., Chioza, B., Andersson, J.L., Russ, C., Shaw, C.E., Powell, J.F., and Leigh, P.N. (1999). Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet. 8, 157-164.
2. Andrus, P.K., Fleck, T.J., Gurney, M.E., and Hall, E.D. (1998). Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 71, 2041-2048.
3. Beckman, J.S., Carson, M., Smith, C.D., and Koppenol, W.H. (1993). ALS, SOD and peroxynitrite. Nature 364, 584.
4. Borchelt, D.R., Lee, M.K., Slunt, H.S., Guarnieri, M., Xu, Z.S., Wong, P.C., Brown, R.H., Jr., Price, D.L., Sisodia, S.S., and Cleveland, D.W. (1994). Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 91, 8292-8296.
5. Bowling, A.C., Schulz, J.B., Brown, R.H., Jr., and Beal, M.F. (1993). Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322-2325.
6. Brown, R.H. (1995). Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80, 687-692.
7. Bruening, W., Roy, J., Giasson, B., Figlewicz, D.A., Mushynski, W.E., and Durham, H.D. (1999). Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem. 72, 693-699.
8. Bruijn, L.I., Beal, M.F., Becher, M.W., Schulz, J.B., Wong, P.C., Price, D.L., and Cleveland, D.W. (1997a). Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxidase dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 94, 7606-7611.
9. Bruijn, L.I., Becher, M.W., Lee, M.K., Anderson, K.L., Jenkins, N.A., Copeland, N.G., Sisodia, S.S., Rothstein, J.D., Borchelt, D.R., Price, D.L., and Cleveland, D.W. (1997b). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338.
10. Bruijn, L.I., Houseweart, M.K., Kato, S., Anderson, K.A., Anderson, S.D., Ohama, E., Reaume, A.G., Scott, R.W., and Cleveland, D.W. (1998). Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851 -1854.
11. Corson, L.B., Strain, J., Culotta, V.C., and Cleveland, D.W. (1998). Chaperone-facilitated loading of copper is a common in vivo property of familial ALS-linked SOD1 mutants. Proc. Natl. Acad. Sci. USA 95, 6361-6366.
12. Couillard-Despres, S., Zhu, Q., Wong, P., Price, D.L., Cleveland, D.W., and Julien, J.-P. (1998). Protective effect of neurofilament NF-H overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. USA 95, 9626-9630.
13. Cudkowicz, M.E., McKenna-Yasek, D., Sapp, P.E., Chin, W., Geller, B., Hayden, D.L., Schoenfeld, D.A., Hosler, B.A., Horvitz, H.R., and Brown, R.H. (1997). Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41, 210-221.
14. Culotta, V.C., Klomp, L.W.J., Strain, J., Casaren, R.L.B., Krems, B., and Gitlin, J.D. (1997). The copper chaperone for superoxide dismutase. J. Biol. Chem. 272, 23469-23472.
15. Durham, H.D., Roy, J., Dong, L., and Figlewicz, D.A. (1997). Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol. 56, 52-56.
16. Ferrante, R.J., Browne, S.E., Shinobu, L.A., Bowling, A.C., Baik, M.J., MacGarvey, U., Kowall, N.W., Brown, R.H., Jr., and Beal, M.F. (1997). Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064-2074.
17. Figlewicz, D.A., Krizus, A., Martinoli, M.G., Meininger, V., Dib, M., Rouleau, G.A., and Julien, J.P. (1994). Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3, 1757-1761.
18. Friedlander, R.M., Brown, R.H., Gagliardini, V., Wang, J., and Yuan, J. (1997). Inhibition of ICE slows ALS in mice. Nature 388, 31.
19. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., and Deng, H.X. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775.
20. Gurney, M.E., Cutting, F.B., Zhai, P., Doble, A., Taylor, C.P., Andrus, P.K., and Hall, E.D. (1996). Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
21. Hirano, A., Donnenfeld, H., Sasaki, S., and Nakano, I. (1984a). Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43, 461-470.
22. Hirano, A., Nakano, I., Kurland, L.T., Mulder, D.W., Holley, P.W., and Saccomanno, G. (1984b). Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43, 471-480.
23. Kawamura, Y., Dyck, P.J., Shimono, M., Okazaki, H., Tateishi, J., and Doi, H. (1981). Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 40, 667-675.
24. Klivenyi, P., Ferrante, R.J., Matthews, R.T., Bogdanov, M.B., Klein, A.M., Andreassen, O.A., Meuller, G., Wermer, M., Kaddurah-Daouk, R., and Beal, M.F. (1999). Neuroprotective effects of creatin in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5, 347-350.
25. Kostic, V., Jackson-Lewis, V., deBilbao, F., Dubois-Dauphin, M., and Przedborski, S. (1997). Bcl-2 prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559-562.
26. Lacomblez, L., Bensimon, G., Leigh, P.N., Guillet, P., and Meininger, V. (1996). Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347, 1425-1431.
27. Lin, C.L., Bristol, L.A., Jin, L., Dykes-Hoberg, M., Crawford, T., Clawson, L., and Rothstein, J.D. (1998). Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589-602.
28. Nagai, M., Abe, K., Okamoto, K., and Itoyama, Y. (1998). Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci. Lett. 244,165-168.
29. Reaume, A.B., Elliott, J.L., Hoffman, E.K., Kowall, N.W., Ferrante, R.J., Siwek, D.F., Wilcox, H.M., Flood, D.G., Beal, M.F., Brown, R.H., et al. (1996). Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13, 43-47.
30. Ripps, M.E., Huntley, G.W., Hof, P.R., Morrison, J.H., and Gordon, J.W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 92, 689-693.
31. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
32. Rothstein, J.D.,Van Kammen,M., Levey, A.I., Martin, LJ., and Kuncl, R.W. (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
33. Singh, R.J., Karoui, H., Gunther, M.R., Beckman, J.S., Mason, R.P., and Kalyanaraman, B. (1998). Reexamination of the mechanism of hydroxyl radical adducts formed from the reaction between familial amyotrophic lateral sclerosis-associated Cu,Zn superoxide dismutase mutants and hydrogen peroxide. Proc. Natl. Acad. Sci. USA 95, 6675-6680.
34. Tomkins, J., Usher, P., Slade, J.Y., Ince, P.G., Curtis, A., Bushby, K., and Shaw, P.J. (1998). Novel insertion in the KSP repeat region of the neurofilament heavy gene in amyotrophic lateral sclerosis. Neuroreport 9, 3967-3970.
35. Trotti, D., Rolfs, A., Danbolt, N.C., Brown, R.H., Jr., and Hediger, M.A. (1999). SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2, 427-433.
36. Warita, H., Itoyama, Y., and Abe, K. (1999). Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 819, 120-131.
37. Wiedau-Pazos, M., Goto, J.J., Rabizadeh, S., Gralla, E.D., Roe, J.A., Valentine, J.S., and Bredesen, D.E. (1996). Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518.
38. Williamson, T.L., and Cleveland, D.W. (1999). Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2, 50-56.
39. Williamson, T.L., Bruijn, L.I., Zhu, Q., Anderson, K.L., Anderson, S.D., Julien, J.-P., and Cleveland, D.W. (1998). Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 95,2631-2636.
40. Wong, P.C., Pardo, C.A., Borchelt, D.R., Lee, M.K., Copeland, N.G., Jenkins, N.A., Sisodia, S.S., Cleveland, D.W., and Price, D.L. (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.